Meal timing study for fatty liver disease
Part of Digestive system clinical trials.
This study tests whether changing when you eat (timing your meals) can improve fatty liver disease. You might be eligible if you have a certain body mass index and eat over 14 hours a day.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index is between 25 and 45
- You have been told you have fatty liver disease (MASLD or NASH stages F0-F1)
- You usually eat over a period of 14 hours or more each day
- You have lived in Cyprus for at least one year
- You are registered with the Cyprus National Health System (Gesy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if restricting eating to daytime hours for 12 weeks can reduce liver fat in people with obesity. It aims to help those with fatty liver disease improve their health without medication.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
This study looks at how the timing of meals throughout the day affects your metabolism and health. It involves tracking your eating patterns and answering health questions using your phone or computer.
This trial tests if a diet low in AGEs (harmful compounds in cooked foods) can improve liver function in adults with fatty liver. It may help those who are sedentary and not on other treatments.
This study checks how fatty liver disease (a condition where fat builds up in the liver) affects the heart. If you have this liver condition and are between 18 and 65, you may help doctors understand the link between liver health and heart function.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
Hear when a new MASLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.